These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 33276671)

  • 21. Maysin and Its Flavonoid Derivative from Centipedegrass Attenuates Amyloid Plaques by Inducting Humoral Immune Response with Th2 Skewed Cytokine Response in the Tg (APPswe, PS1dE9) Alzheimer's Mouse Model.
    Song Y; Kim HD; Lee MK; Hong IH; Won CK; Bai HW; Lee SS; Lee S; Chung BY; Cho JH
    PLoS One; 2017; 12(1):e0169509. PubMed ID: 28072821
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological modulation of GSAP reduces amyloid-β levels and tau phosphorylation in a mouse model of Alzheimer's disease with plaques and tangles.
    Chu J; Lauretti E; Craige CP; Praticò D
    J Alzheimers Dis; 2014; 41(3):729-37. PubMed ID: 24662099
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms of Hydrogen Sulfide against the Progression of Severe Alzheimer's Disease in Transgenic Mice at Different Ages.
    Vandini E; Ottani A; Zaffe D; Calevro A; Canalini F; Cavallini GM; Rossi R; Guarini S; Giuliani D
    Pharmacology; 2019; 103(1-2):50-60. PubMed ID: 30448835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic Effects of Human Amniotic Epithelial Stem Cells in a Transgenic Mouse Model of Alzheimer's Disease.
    Kim KY; Suh YH; Chang KA
    Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32290355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuronal Protein Tyrosine Phosphatase 1B Hastens Amyloid β-Associated Alzheimer's Disease in Mice.
    Ricke KM; Cruz SA; Qin Z; Farrokhi K; Sharmin F; Zhang L; Zasloff MA; Stewart AFR; Chen HH
    J Neurosci; 2020 Feb; 40(7):1581-1593. PubMed ID: 31915254
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lack of human-like extracellular sortilin neuropathology in transgenic Alzheimer's disease model mice and macaques.
    Zhou FQ; Jiang J; Griffith CM; Patrylo PR; Cai H; Chu Y; Yan XX
    Alzheimers Res Ther; 2018 Apr; 10(1):40. PubMed ID: 29690919
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sex Differences in Neuropathology and Cognitive Behavior in APP/PS1/tau Triple-Transgenic Mouse Model of Alzheimer's Disease.
    Yang JT; Wang ZJ; Cai HY; Yuan L; Hu MM; Wu MN; Qi JS
    Neurosci Bull; 2018 Oct; 34(5):736-746. PubMed ID: 30099679
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunolesion-induced loss of cholinergic projection neurones promotes β-amyloidosis and tau hyperphosphorylation in the hippocampus of triple-transgenic mice.
    Härtig W; Saul A; Kacza J; Grosche J; Goldhammer S; Michalski D; Wirths O
    Neuropathol Appl Neurobiol; 2014 Feb; 40(2):106-20. PubMed ID: 23566195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A fragment of cell adhesion molecule L1 reduces amyloid-β plaques in a mouse model of Alzheimer's disease.
    Hu J; Lin SL; Schachner M
    Cell Death Dis; 2022 Jan; 13(1):48. PubMed ID: 35013124
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Abeta deposition and related pathology in an APP x PS1 transgenic mouse model of Alzheimer's disease.
    Howlett DR; Bowler K; Soden PE; Riddell D; Davis JB; Richardson JC; Burbidge SA; Gonzalez MI; Irving EA; Lawman A; Miglio G; Dawson EL; Howlett ER; Hussain I
    Histol Histopathol; 2008 Jan; 23(1):67-76. PubMed ID: 17952859
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term central pathology and cognitive impairment are exacerbated in a mixed model of Alzheimer's disease and type 2 diabetes.
    Infante-Garcia C; Ramos-Rodriguez JJ; Galindo-Gonzalez L; Garcia-Alloza M
    Psychoneuroendocrinology; 2016 Mar; 65():15-25. PubMed ID: 26708068
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative Comparison of Dense-Core Amyloid Plaque Accumulation in Amyloid-β Protein Precursor Transgenic Mice.
    Liu P; Reichl JH; Rao ER; McNellis BM; Huang ES; Hemmy LS; Forster CL; Kuskowski MA; Borchelt DR; Vassar R; Ashe KH; Zahs KR
    J Alzheimers Dis; 2017; 56(2):743-761. PubMed ID: 28059792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prenatal hypoxia may aggravate the cognitive impairment and Alzheimer's disease neuropathology in APPSwe/PS1A246E transgenic mice.
    Zhang X; Li L; Zhang X; Xie W; Li L; Yang D; Heng X; Du Y; Doody RS; Le W
    Neurobiol Aging; 2013 Mar; 34(3):663-78. PubMed ID: 22795785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liver Growth Factor (LGF) Upregulates Frataxin Protein Expression and Reduces Oxidative Stress in Friedreich's Ataxia Transgenic Mice.
    Calatrava-Ferreras L; Gonzalo-Gobernado R; Reimers D; Herranz AS; Casarejos MJ; Jiménez-Escrig A; Regadera J; Velasco-Martín J; Vallejo-Muñoz M; Díaz-Gil JJ; Bazán E
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27941692
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
    Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
    Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SLOH, a carbazole-based fluorophore, mitigates neuropathology and behavioral impairment in the triple-transgenic mouse model of Alzheimer's disease.
    Wu X; Kosaraju J; Zhou W; Tam KY
    Neuropharmacology; 2018 Mar; 131():351-363. PubMed ID: 29309769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human tau increases amyloid β plaque size but not amyloid β-mediated synapse loss in a novel mouse model of Alzheimer's disease.
    Jackson RJ; Rudinskiy N; Herrmann AG; Croft S; Kim JM; Petrova V; Ramos-Rodriguez JJ; Pitstick R; Wegmann S; Garcia-Alloza M; Carlson GA; Hyman BT; Spires-Jones TL
    Eur J Neurosci; 2016 Dec; 44(12):3056-3066. PubMed ID: 27748574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IL-6 trans-signaling in the brain influences the behavioral and physio-pathological phenotype of the Tg2576 and 3xTgAD mouse models of Alzheimer's disease.
    Escrig A; Canal C; Sanchis P; Fernández-Gayol O; Montilla A; Comes G; Molinero A; Giralt M; Giménez-Llort L; Becker-Pauly C; Rose-John S; Hidalgo J
    Brain Behav Immun; 2019 Nov; 82():145-159. PubMed ID: 31401302
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z
    Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747
    [TBL] [Abstract][Full Text] [Related]  

  • 40. beta-amyloid deposits in transgenic mice expressing human beta-amyloid precursor protein have the same characteristics as those in Alzheimer's disease.
    Terai K; Iwai A; Kawabata S; Tasaki Y; Watanabe T; Miyata K; Yamaguchi T
    Neuroscience; 2001; 104(2):299-310. PubMed ID: 11377835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.